| Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade BC Miller, DR Sen, R Al Abosy, K Bi, YV Virkud, MW LaFleur, KB Yates, ... Nature immunology 20 (3), 326-336, 2019 | 1709 | 2019 |
| In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target RT Manguso, HW Pope, MD Zimmer, FD Brown, KB Yates, BC Miller, ... Nature 547 (7664), 413-418, 2017 | 1122 | 2017 |
| PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity VR Juneja, KA McGuire, RT Manguso, MW LaFleur, N Collins, ... Journal of Experimental Medicine 214 (4), 895-904, 2017 | 865 | 2017 |
| Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade JJ Ishizuka, RT Manguso, CK Cheruiyot, K Bi, A Panda, A Iracheta-Vellve, ... Nature 565 (7737), 43-48, 2019 | 587 | 2019 |
| Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity GK Griffin, J Wu, A Iracheta-Vellve, JC Patti, J Hsu, T Davis, D Dele-Oni, ... Nature 595 (7866), 309-314, 2021 | 268 | 2021 |
| An expanded universe of cancer targets WC Hahn, JS Bader, TP Braun, A Califano, PA Clemons, BJ Druker, ... Cell 184 (5), 1142-1155, 2021 | 177 | 2021 |
| In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer J Dubrot, PP Du, SK Lane-Reticker, EA Kessler, AJ Muscato, A Mehta, ... Nature Immunology 23 (10), 1495-1506, 2022 | 122 | 2022 |
| EB1 and EB3 promote cilia biogenesis by several centrosome-related mechanisms JM Schrøder, J Larsen, Y Komarova, A Akhmanova, RI Thorsteinsson, ... Journal of cell science 124 (15), 2539-2551, 2011 | 111 | 2011 |
| Primary cilia and aberrant cell signaling in epithelial ovarian cancer DL Egeberg, M Lethan, R Manguso, L Schneider, A Awan, TS Jørgensen, ... Cilia 1, 1-17, 2012 | 106 | 2012 |
| Mutant IDH inhibits IFNγ–TET2 signaling to promote immunoevasion and tumor maintenance in cholangiocarcinoma MJ Wu, L Shi, J Dubrot, J Merritt, V Vijay, TY Wei, E Kessler, KE Olander, ... Cancer discovery 12 (3), 812-835, 2022 | 99 | 2022 |
| Targeting TBK1 to overcome resistance to cancer immunotherapy Y Sun, O Revach, S Anderson, EA Kessler, CH Wolfe, A Jenney, CE Mills, ... Nature 615 (7950), 158-167, 2023 | 87 | 2023 |
| Functional genomics identifies metabolic vulnerabilities in pancreatic cancer DE Biancur, KS Kapner, K Yamamoto, RS Banh, JE Neggers, ASW Sohn, ... Cell metabolism 33 (1), 199-210. e8, 2021 | 81 | 2021 |
| TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response Z Zeng, CJ Wong, L Yang, N Ouardaoui, D Li, W Zhang, S Gu, Y Zhang, ... Nucleic acids research 50 (D1), D1391-D1397, 2022 | 79 | 2022 |
| The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity CK Baumgartner, H Ebrahimi-Nik, A Iracheta-Vellve, KM Hamel, ... Nature 622 (7984), 850-862, 2023 | 78 | 2023 |
| In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma J Dubrot, SK Lane-Reticker, EA Kessler, A Ayer, G Mishra, CH Wolfe, ... Immunity 54 (3), 571-585. e6, 2021 | 75 | 2021 |
| PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment NB Collins, R Al Abosy, BC Miller, K Bi, Q Zhao, M Quigley, JJ Ishizuka, ... Journal for ImmunoTherapy of Cancer 10 (3), 2022 | 40 | 2022 |
| Extracellular matrix proteins regulate NK cell function in peripheral tissues MD Bunting, M Vyas, M Requesens, A Langenbucher, EB Schiferle, ... Science advances 8 (11), eabk3327, 2022 | 34 | 2022 |
| Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders L Zhou, Z Zeng, AM Egloff, F Zhang, F Guo, KM Campbell, P Du, J Fu, ... Journal for immunotherapy of cancer 10 (1), 2022 | 34 | 2022 |
| Tumor-derived PGE2 gives NK cells a headache NH Knudsen, RT Manguso Immunity 53 (6), 1131-1132, 2020 | 18 | 2020 |
| Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity MJ Wu, H Kondo, AV Kammula, L Shi, Y Xiao, S Dhiab, Q Xu, CJ Slater, ... Science 385 (6705), eadl6173, 2024 | 16 | 2024 |
Nick HainingAssistant Professor, Harvard Medical SchoolVerified email at dfci.harvard.edu